103 related articles for article (PubMed ID: 4587961)
1. [Results of Paveron 75 therapy in negatively selected patients with cerebral function disorders].
Klaus P; Wiethaup H
Med Welt; 1973 Sep; 24(37):1413-4. PubMed ID: 4587961
[No Abstract] [Full Text] [Related]
2. [Long term treatment with delayed strong solurutine papaverine].
Vincendeau MJ
Bord Med; 1971 Nov; 4(11):3347-50. PubMed ID: 5002837
[No Abstract] [Full Text] [Related]
3. Papaverin in the treatment of geriatric patients.
Bambasová E; Bílková J; Budínská K
Act Nerv Super (Praha); 1974 Aug; 16(3):191-2. PubMed ID: 4609360
[No Abstract] [Full Text] [Related]
4. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
Probst G; Keiser G
Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
[No Abstract] [Full Text] [Related]
5. [Experience with the combination of vincamine and papaverine in chronic brain syndrome].
Cacciatori D
Clin Ter; 1979 Jun; 89(5):473-82. PubMed ID: 535324
[No Abstract] [Full Text] [Related]
6. [Use of thyroidin in combination with vitamins C, B-6 and B-12 in cerebral arteriosclerosis].
Komorovskaia IaM
Vrach Delo; 1965 May; 5():54-9. PubMed ID: 5854497
[No Abstract] [Full Text] [Related]
7. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency].
Komorovskaia IaM; Nechaĭ EE
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974
[TBL] [Abstract][Full Text] [Related]
8. [New aspects in the therapy of cerebrovascular diseases. Hemodynamic studies with a combination of coumarin-rutin-theophylline].
Klein K
Arzneimittelforschung; 1974 Jul; 24(7):1066-9. PubMed ID: 4408076
[No Abstract] [Full Text] [Related]
9. [The effects of the combined use of mineral water with ascorbic acid and rutin experimentally and clinically].
Polushina ND; Kartazaeva VA; Botvineva LA; Kozhevnikov SA
Vopr Kurortol Fizioter Lech Fiz Kult; 2000; (2):31-4. PubMed ID: 11094893
[TBL] [Abstract][Full Text] [Related]
10. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
Bazo AJ
J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
[No Abstract] [Full Text] [Related]
11. [Clinical ophthalmodynamographic results of the treatment of cerebral circulation disorders with O-(beta-hydroxyethyl)-rutoside].
Tzavellas O
Arzneimittelforschung; 1970 Sep; 20(9):1187-90. PubMed ID: 5536794
[No Abstract] [Full Text] [Related]
12. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
[No Abstract] [Full Text] [Related]
13. [Effectiveness of electrophoresis of novocaine in combination with ascorbic acid in the treatment of cerebral atherosclerosis].
Efendieva FM; Shakhnazarov BB; Kravets IL; Kochergina EK
Vopr Kurortol Fizioter Lech Fiz Kult; 1965; 30(3):206-9. PubMed ID: 5881815
[No Abstract] [Full Text] [Related]
14. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
[No Abstract] [Full Text] [Related]
15. [Use of theophyllinyl 7- -n propane sulfonate of papaverine in rehabilitation and functional readaptation].
Blanc A; Perset P
Therapeutique; 1971 Apr; 47(4):391-3. PubMed ID: 5564052
[No Abstract] [Full Text] [Related]
16. [Diagnostic and therapeutic difficulties in cerebral atherosclerosis (author's transl)].
Zdichynec B
Cesk Psychiatr; 1974 Feb; 70(1):42-6. PubMed ID: 4452124
[No Abstract] [Full Text] [Related]
17. [Treatment and prevention of cerebral arterial disorders in aged and of their consequences. Rheoencephalographic examinations].
Albot G; Goutmer B; Treps J
Therapeutique; 1971; 47(6):579-84. PubMed ID: 5571174
[No Abstract] [Full Text] [Related]
18. [Ambulatory treatment of menstrual disorders after menarche].
Finková A
Cesk Gynekol; 1975 Mar; 40(2):89-90. PubMed ID: 1169125
[No Abstract] [Full Text] [Related]
19. Papaverine hydrochloride as therapy for mentally confused geriatric patients.
LaBrecque DC
Curr Ther Res Clin Exp; 1966 Mar; 8(3):106-9. PubMed ID: 4956578
[No Abstract] [Full Text] [Related]
20. Management of chronic brain syndrome secondary to cerebral arteriosclerosis, with special reference to papaverine hydrochloride.
Stern FH
J Am Geriatr Soc; 1970 Jun; 18(6):507-12. PubMed ID: 4910976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
